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Abstract
The hypothalamic-pituitary-adrenal axis, with cortisol as its final metabolite, has been pro-
posed as a potential underlying biological mechanism for associations between depression
and stress symptoms during pregnancy and adverse perinatal outcomes. In this study, we
explored associations between salivary cortisol as a potential biomarker for stress and
depressive symptoms and several self-completed psychological measurement scales
among pregnant women. In total, 652 pregnant women participating in the PRegnancy and
Infant DEvelopment (PRIDE) Study completed the Edinburgh Depression Scale (EDS),
Patient Health Questionnaire-2 (PHQ-2), Pregnancy-Related Anxiety Questionnaire-
Revised (PRAQ-R), and Tilburg Pregnancy Distress Scale (TPDS) and collected a single
awakening salivary cortisol sample around gestational week 17. Odds ratios, Spearman’s
correlation coefficients (ρs) and Cohen’s Kappa coefficients (κ) were calculated to examine
the associations between the EDS, PHQ-2, PRAQ-R, TPDS, and maternal cortisol levels.
The overall correlation coefficient between the score on the EDS and the salivary cortisol
level was 0.01 (p = 0.89) with κ = -0.01 (95% confidence interval [CI] -0.08–0.06). We did
not observe agreement between the PHQ-2 and cortisol levels either (κ = 0.06 (95% CI
-0.02–0.14)). The results for the PRAQ-R and TPDS were similar with overall correlations
with maternal cortisol levels of ρs = 0.01 (p = 0.81) and ρs = 0.06 (p = 0.35) and agreements
of κ = 0.02 (95% CI -0.06–0.09) and κ = -0.02 (95% CI -0.11–0.07), respectively. Maternal
awakening salivary cortisol levels and measures of maternal psychological distress, anxiety,
depressive symptoms, and pregnancy-related anxiety, assessed by self-completed ques-
tionnaires, did not seem to be related in mid-pregnancy.
Introduction
Depression and stress disorders during pregnancy have been associated with adverse effects on
the health of the mother and the unborn child [1–4]. Therefore, it is important to diagnose
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these disorders as early in pregnancy as possible. Although the aetiology has not been fully
understood yet, disturbances in the hypothalamic-pituitary-adrenal (HPA) axis have been pro-
posed as a potential underlying biological mechanism linking depression and stress symptoms
during pregnancy with adverse fetal and child outcomes [5–7]. Cortisol is the final metabolite
in the HPA axis and is often related to the state of stress and depression [8]. Especially since
cortisol can easily be measured in saliva using a cheap and non-invasive method, it might be a
useful biomarker to assess stress and/or depression. Previous studies showed that awakening
salivary cortisol levels are reliable biomarkers for measuring an individual’s cortisol concentra-
tions compared to levels measured throughout the day [9–11].
For research purposes, stress and depressive symptoms are typically identified by the use of
self-administered questionnaires. Several questionnaires exist to assess different aspects of psy-
chological well-being, some of which are also used in clinical settings. Research findings sug-
gest that depression and stress symptoms are associated with elevated diurnal cortisol levels
among non-pregnant women [12, 13]. However, this finding cannot be extrapolated straight-
away to pregnant women due to pregnancy-related changes in the HPA axis as well as changes
in the immune system and hormone levels [14]. This leads to a controversy in the literature
about the existence of an association between stress and depressive symptoms assessed
through self-administered questionnaires and cortisol levels measured in saliva among preg-
nant women [15–17]. Depressive symptoms, anxiety disorders, and stress are often associated
with similar genes [18, 19], which suggests common underlying neurophysiological mecha-
nisms. However, reported symptoms often differ between the above-mentioned mood disor-
ders [20]. Therefore, we aimed to explore the associations between cortisol level as a potential




This study was embedded in a large ongoing prospective cohort study, the PRegnancy and
Infant DEvelopment (PRIDE) Study, and was reported according to the STROBE guidelines
[21]. The PRIDE Study enrolls Dutch women early in pregnancy. Details of the study design
are described elsewhere [22, 23]. In short, pregnant women aged 18 years and older are invited
to participate in the PRIDE Study by their midwife or gynecologist just before or during their
first prenatal care visit. They are asked to complete Web-based questionnaires at baseline, in
gestational weeks 17 (questionnaire 2, Q2) and 34 (questionnaire 3), as well as 2 and 6 months
after delivery. Questions concern demographic factors, reproductive history, maternal health,
lifestyle factors, and occupational exposures. The prenatal questionnaires also include several
measurement scales to assess stress, anxiety, and depressive symptoms. Q2 includes the Edin-
burgh Depression Scale (EDS), the Patient Health Questionnaire-2 (PHQ-2), and the revised
version of the Pregnancy-Related Anxiety Questionnaire (PRAQ-R). These questionnaires
were careful selected based on their sensitivity and specificity. The questionnaires are widely
used and validated in primary care settings including general and pregnant populations.
For this study, we selected all PRIDE Study participants who completed Q2 between April
2012 and May 2016 (n = 3,027). The PRIDE Study was approved by the Regional Committee
on Research involving Human Subjects and all participants provided informed consent.
After completing Q2, participants are asked to donate a single awakening saliva sample.
Participants who agree to do so, receive a Salivette1 (Sarstedt AG & Co, Nümbrecht, Ger-
many) to collect saliva by regular mail. Samples are taken within 10 minutes after awakening
on a working day, before teeth brushing, eating, drinking, or smoking. On the informed
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consent form, the women are asked to record the date, time of awaking, and time of saliva col-
lection. All samples are returned to the research site in a special envelope for biological materi-
als by regular mail with a median of 3 days between saliva collection and receipt of the sample.
For the current study, women who participated between December 2014 and May 2016 also
received a paper-based version of the Tilburg Pregnancy Distress Scale (TPDS) along with the
Salivette1, which we asked to complete on the same day as the saliva sample collection. This
questionnaire was included to examine possible effects of the time interval between saliva sam-
pling and self-reporting of depression or stress symptoms in the other three measurement scales
administered at least 3 days preceding salivary cortisol collection. The women in this subgroup
returned the cortisol sample together with the TPDS questionnaire by regular mail as well.
Questionnaire characteristics
Edinburgh Depression Scale. The EDS is a 10-item self-rating depression scale com-
monly used to assess depressive symptoms, and is validated for pregnant and postpartum
women in the Netherlands [24, 25]. A cut-off value of 10 or greater indicates a positive score
for a possible depression on a total scale of 0–30. The EDS consists of two subscales, a depres-
sion and a stress subscale.
Patient Health Questionnaire-2. The PHQ-2 exists of two questions screening for
depressive symptoms. The questions are formulated based on the National Institute for Health
and Care Excellence (NICE) guidelines. Patients who screen positive answered at least one
question with ‘yes’ [26–28].
Pregnancy-Related Anxiety Questionnaire-R. The PRAQ-R is a shortened version of the
PRAQ developed by Van den Bergh [29]. The PRAQ-R is used to assess state and trait anxiety
and depression related to pregnancy with a total score range of 10–40 [30]. The 90th percentile
cut-off point is used to screen women as positive [31].
Tilburg Pregnancy Distress Scale. The TPDS is a questionnaire especially developed to
assess pregnancy-related distress among Dutch pregnant women and to pick up negative emo-
tions regarding confinement, delivery, and general health. It includes two sub-scales measur-
ing perceived partner involvement and negative effects. An overall cut-off value of 18 or
higher on a total scale of 0–48 indicates a positive score [32].
Inclusion and exclusion criteria
From the PRIDE Study participants who donated a saliva sample, we excluded all women who
did not adhere to the sampling protocol and those who donated an insufficient amount of
saliva. In addition, we excluded the samples that were received>14 days after sampling, as
well as the samples collected>1 month after completion of Q2. For efficiency reasons, we ran-
domly selected 50% of eligible saliva samples for analysis, with oversampling of samples from
women who scored positive on the EDS, PRAQ-R, PHQ-2, and/or TPDS.
Cortisol assay
Upon receipt at the study site, the saliva samples were immediately stored at -20˚C until analy-
sis. At LDN Labor Diagnostika Nord GmbH & Co. KG, Nordhorn, Germany, the frozen sam-
ples were thawed and centrifuged for 5 to 10 minutes at 2000–3000 x g. The Cortisol free in
Saliva ELISA Kit (Cortisol Saliva ELISAfree Kit) was used to determine the concentration of
cortisol in the samples. Of the standard reagent, the control reagent, and the saliva sample,
50 μL was dispensed in microtiter wells, as well as 50 μL of a cortisol-horseradish peroxidase
conjugate for binding to the coated antibody. The wells were incubated for 60 minutes at
room temperature. Afterwards, they were rinsed 3 times with 300 μL diluted wash solution
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and 200 μL of substrate solution was added. Again, the wells were incubated for 30 minutes at
room temperature and 50 μL of stop solution was added to each well. The absorbance of each
well was determined with the use of a microtiter plate calibrated reader at 450 ± 10 nm within
15 minutes.
Statistical analyses
Descriptive statistics were used to describe the general characteristics of the women included
in this study. Independent sample t-tests were performed to compare the mean salivary corti-
sol levels between the women with positive and negative scores on all questionnaires separately
using the standardized cut-off values. In addition, the awakening cortisol levels were dichoto-
mized to classify women as having elevated cortisol levels. Currently no clinically relevant
threshold value exists, but in a previous study, we showed that the 75th percentile was a reliable
cut-off to classify women as having normal or elevated cortisol levels [11]. Logistic regression
analysis was used to estimate odd ratios (OR) with 95% confidence intervals (95% CI) for the
associations between the dichotomized questionnaire scores and elevated cortisol levels. We
calculated the Spearman’s rank correlation coefficient (ρs) to analyze the correlations between
the continuous EDS, PRAQ-R, and TPDS scores and the awakening cortisol levels. Cohen’s
Kappa coefficients (κ) with 95% confidence intervals were calculated to quantify the degree of
agreement between the dichotomized EDS, PRAQ-R, PHQ-2, and TPDS scores and elevated
awakening cortisol levels taking agreement occurring by chance into account.
In sub-analyses, we stratified the primary analyses by maternal age (<30, 30–34,�35
years), level of education (low/moderate vs. high), country of birth (The Netherlands vs.
other), pre-pregnancy Body Mass Index (BMI; <25.0 vs.�25.0 kg/m2), parity (0 previous
births vs.�1 previous birth), gestational week at completing Q2 (split at the median of 17
weeks), gestational week at saliva sampling (split at the median of 19 weeks), days between
completing Q2 and saliva sampling (�14 days, >14 days), awakening time (�7 a.m. vs. >7 a.
m.), difference between awakening time and collection time (�5 min vs. 6–10 min), and infant
sex (male vs. female) to examine the correlations and Kappa coefficients among these sub-
groups. All statistical analyses were performed using the Statistical Package for Social Sciences
(SPSS), version 22.0 for Windows (IBM Corp., Armonk, NY).
Results
A total of 1,728 out of the 3,019 PRIDE Study participants who completed Q2 in the study
period also donated a saliva sample (57.2%), of which 1,304 (75.5%) met the inclusion criteria.
Therefore, 652 women were included in this study. The study population included 91 women
who scored positive on the EDS, 78 who scored positive on the PRAQ-R, 162 who scored posi-
tive on the PHQ-2, and 27 who scored positive on the TPDS. Of note, only 278 women in our
study population completed the TPDS.
The average moment of completion of the second PRIDE Study questionnaire, including
the EDS, PHQ-2, and PRAQ-R, was gestational week 17 (standard deviation [SD] 1.6), and the
average moment of awakening saliva sample collection was gestational week 19 (SD 1.9), mak-
ing the average time between completing Q2 and collecting the salivary cortisol sample 15
days (SD 7.2). All women in the subgroup recorded that they completed the TPDS question-
naire and collected the saliva sample at the same day.
The mean concentration of cortisol in all samples was 9.98 ng/ml (SD 6.4), whereas the 75th
percentile, which was used as cut-off value for elevated cortisol levels, was 12.50 ng/ml. We did
not observe differences in the mean cortisol concentrations between women scoring positive
on the EDS, PHQ-2, PRAQ-R, and/or TPDS and the women scoring negative on these
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instruments (Table 1). However, women who scored positive on the PHQ-2 seemed to have an
increased risk of an elevated cortisol level (odds ratio 1.4, 95% CI 0.9–2.0).
In Table 2, the correlations between the awakening salivary cortisol levels and the scores on
the EDS, PHQ-2, and PRAQ-R are shown. The overall correlation between the EDS scores and
the cortisol levels was 0.01 (p = 0.89), while the agreement between both dichotomized mea-
sures was κ = -0.01 (95% CI -0.08–0.06). The agreement between the PHQ-2 and the dichoto-
mized cortisol levels was κ = 0.06 (95% CI -0.02–0.14). The PRAQ-R scores and the cortisol
levels had an overall correlation of 0.01 (p = 0.81) and an agreement of κ = 0.02 (-0.06–0.09),
whereas these values were ρs = 0.06 (p = 0.35) and κ = -0.02 (-0.11–0.07) for the TPDS
(Table 3).
Stratified analyses performed for all maternal characteristics resulted in similarly low corre-
lation and kappa coefficients (Tables 2 and 3). The strongest correlations were observed
among women born outside of The Netherlands (PRAQ-R, ρs = 0.41 [p = 0.070]), among over-
weight/obese women (PRAQ-R, ρs = 0.16 [p = 0.038]), and among women pregnant of a male
infant (EDS, ρs = 0.12 [p = 0.042]). The kappa statistic ranged between -0.17 (95% CI -0.29–
0.04) for the PRAQ-R among women aged�35 years and 0.41 (95% CI -0.01–0.83) for the
PHQ-2 among women born outside of The Netherlands. The analyses on the gestational week
of completing the EDS, PHQ-2, PRAQ-R, or TDPS, gestational week of saliva sampling, inter-
val between completion of the questionnaire and saliva sampling (not applicable to the TPDS),
awakening time, or difference between awakening time and saliva collection time, did not
show any correlations. For these analyses, the kappa statistic ranged between -0.05 (95% CI
-0.15–0.05) for the EDS among women who woke after 7am and 0.23 (95% CI -0.15–0.62) for
the TPDS among women who completed the PRIDE Study questionnaire (not containing the
TPDS) after gestational week 17.
Discussion
In this study, no correlation was observed between maternal awakening salivary cortisol levels
and maternal psychological distress, anxiety or depressive symptoms, and pregnancy-related
Table 1. Comparison of awakening salivary cortisol levels between women who scored positive and negative on the different measurement scales. Data from the
PRIDE Study, 2012–2016.
Measurement scale N Mean (SD) cortisol level Difference (95% CI) Elevated cortisol level
N (%) OR (95% CI)
EDS
Positive 91 9.33 (4.41) -0.73 (-2.15–0.70) 21 (23) 0.9 (0.5–1.6)
Negative 541 10.05 (6.69) Reference 133 (25) Reference
PRAQ-R
Positive 78 10.13 (5.00) 0.14 (-1.37–1.65) 21 (27) 1.1 (0.7–1.9)
Negative 565 9.99 (6.55) Reference 139 (25) Reference
PHQ-2
Positive 162 10.39 (5.45) 0.52 (-0.61–1.66) 48 (30) 1.4 (0.9–2.0)
Negative 487 9.87 (6.64) Reference 115 (24) Reference
TPDSa
Positive 27 13.20 (20.4) 2.40 (-5.72–10.45) 7 (26) 0.8 (0.3–2.1)
Negative 251 10.80 (4.9) Reference 74 (30) Reference
a The TPDS was not included in PRIDE Study questionnaire Q2, but was completed on the day of saliva sampling by women participating between December 2014 and
May 2016.
https://doi.org/10.1371/journal.pone.0250459.t001
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Table 2. Spearman correlation coefficients and Cohen’s Kappas of awakening cortisol levels and EDS, PHQ-2, and PRAQ-R scores. Data from the PRIDE Study,
2012–2016.
Characteristic EDS PHQ-2 PRAQ-R
N Spearman’s ρ (p-
value)
κ (95% CI) N κ (95% CI) N Spearman’s ρ (p-
value)
κ (95% CI)




643 0.01 (0.81) 0.02 (-0.06–
0.09)
Maternal age (yrs)
<30 247 -0.03 (0.66) 0.00 (-0.12–
0.13)
254 0.11(-0.03–0.24) 253 0.05 (0.46) 0.05 (-0.08–
0.17)




295 0.07 (0.27) 0.07 (-0.04–
0.18)




94 -0.14 (0.18) -0.17 (-0.29–
0.04)
Level of educationa




130 -0.01 (0.92) 0.04 (-0.13–
0.21)




509 0.04 (0.34) 0.01 (-0.07–
0.09)
Country of birth




619 0.00 (0.92) 0.02 (-0.06–
0.09)




20 0.41 (0.07) 0.23 (-0.28–
0.75)
Pre-pregnancy BMI (kg/m2)b




479 -0.05 (0.31) -0.02 (-0.09–
0.06)




160 0.16 (0.04) 0.09 (-0.07–
0.24)
Parity




379 0.05 (0.34) 0.03 (-0.07–
0.13)




261 -0.03 (0.68) 0.01 (-0.07–
0.10)
Gestational week of completing Q2




564 0.00 (0.99) 0.02 (-0.06–
0.09)




76 0.08 (0.49) 0.03 (-0.19–
0.26)
Gestational week of saliva sampling




476 0.00 (0.99) -0.01 (-0.09–
0.07)




164 0.03 (0.70) 0.09 (-0.06–
0.25)
Days between completing Q2 and saliva
sampling




342 0.02 (0.74) -0.01 (-0.10–
0.09)




300 0.00 (0.96) 0.04 (-0.06–
0.14)
Awakening time




335 -0.05 (0.38) -0.01 (-0.10–
0.08)




307 0.09 (0.13) 0.06 (-0.06–
0.18)
(Continued)
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anxiety measured by the EDS, PHQ-2, PRAQ-R, and TPDS, regardless of stratification by
maternal characteristics, gestational week at completing the questionnaires, gestational week
at saliva sampling, time period between questionnaire completion and saliva sampling, awak-
ening time, or time between awakening and saliva sampling. Therefore, the assumption that
psychological characteristics measured by self-completed questionnaires are associated with
hyperactivity of the HPA axis, resulting in elevated cortisol levels, is not supported by this
study.
Our results are consistent with several other studies that did not find associations between
cortisol levels and self-reported measures of psychological functioning among pregnant
women either, including studies measuring cortisol levels in multiple saliva samples across a
wider gestational window [6, 15, 16, 33, 34] or throughout the day to measure the diurnal
rhythm [35], and a study measuring cortisol in serum [36]. Most of these studies had a small
sample size, but even in our large cohort, we did not detect these associations. However, other
studies did show that cortisol levels were associated with self-reported well-being during preg-
nancy [17, 37, 38]. Obel et al. [17] reported an association between major life events and even-
ing cortisol levels in late pregnancy, while morning cortisol levels were unaffected. Pluess et al.
[37] reported an association between cortisol levels and trait anxiety in 66 women in early, but
not in late pregnancy. A third study found an association between an anxiety subscale on corti-
sol levels at awakening in 170 pregnant women, but none in the overall diurnal cortisol model.
They concluded that more research is needed to understand the underlying mechanisms of the
association and the search for mechanisms other than the HPA-axis [38]. These studies used
different measures of psychological well-being at different time points, finding only a weak
association with one of the measures or at one time point, and several nonexistent ones. A
recent systematic review by Orta et al. [39] concluded that most studies reported no associa-
tion between maternal cortisol level and antepartum depression.
The strengths of the current study are the large sample size, the availability of information
on many maternal characteristics during pregnancy, and measurements of symptoms of
depression, anxiety, and stress by means of several different questionnaires. The EDS, PHQ-2,
PRAQ-R, and TPDS are all validated questionnaires measuring different psychological charac-
teristics, such as pregnancy-related anxiety (PRAQ-R), state and trait anxiety (PRAQ-R),
Table 2. (Continued)
Characteristic EDS PHQ-2 PRAQ-R
N Spearman’s ρ (p-
value)
κ (95% CI) N κ (95% CI) N Spearman’s ρ (p-
value)
κ (95% CI)
Time between awakening and saliva
sampling




422 0.02 (0.63) -0.02 (-0.10–
0.07)




220 -0.01 (0.87) 0.09 (-0.04–
0.22)
Infant sex
Male 296 0.12 (0.04) 0.11 (-0.01–
0.23)
304 0.16 (0.03–0.28) 304 0.10 (0.08) 0.05 (-0.06–
0.16)




325 -0.10 (0.09) -0.01 (-0.11–
0.09)
b Low/moderate level of education includes no education, lower general secondary education, intermediate vocational education, higher general secondary education,
and pre-university education; High level of education includes higher vocational education and university.
c BMI: Body Mass Index
https://doi.org/10.1371/journal.pone.0250459.t002
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depressive symptoms (EDS), pregnancy distress (TDPS), and maternal stress (PHQ-2). By
adding a subgroup of women completing the TPDS and collecting the salivary cortisol sample
at the same day, potential bias due to the time interval between sampling and reporting of
symptoms of depression or stress could be ruled out.
A limitation of our study might be the collection of a single salivary cortisol sample,
through which we were not able to measure the cortisol awakening response or the circadian
Table 3. Spearman correlation coefficients and Cohen’s Kappas of awakening cortisol levels and Tilburg Preg-
nancy Distress Scale (TPDS) scores in a subpopulation.
Characteristic TPDSa
N Spearman’s ρ (p-value) κ (95% CI)
Overall 278 0.06 (0.35) -0.02 (-0.11–0.07)
Maternal age (yrs)
<30 108 0.07 (0.50) -0.06 (-0.20–0.09)
30–34 123 -0.03 (0.79) 0.05 (-0.12–0.22)
�35 47 0.16 (0.28) -0.07 (-0.24–0.10)
Level of educationb
Low/moderate 49 -0.02 (0.89) 0.16 (-0.09–0.42)
High 227 0.09 (0.16) -0.07 (-0.15–0.02)
Country of birth
The Netherlands 267 0.07 (0.29) -0.01 (-0.11–0.08)
Other 9 0.34 (0.38) -0.13 (-0.30–0.05)
Pre-pregnancy BMI (kg/m2)c
<25.0 208 0.05 (0.50) -0.05 (-0.14–0.05)
�25.0 69 0.08 (0.51) 0.02 (-0.18–0.21)
Parity
0 previous births 153 0.08 (0.31) 0.01 (-0.13–0.15)
�1 previous births 124 0.01 (0.94) -0.04 (-0.15–0.07)
Gestational week of completing Q2
�17 251 0.04 (0.50) -0.04 (-0.14–0.06)
>17 25 0.17 (0.41) 0.23 (-0.15–0.62)
Gestational week of saliva sampling
�19 219 0.03 (0.63) -0.04 (-0.15–0.06)
>19 57 0.14 (0.29) 0.08 (-0.13–0.28)
Awakening time
�7 a.m. 147 0.16 (0.05) 0.00 (-0.11–0.11)
>7 a.m. 131 -0.05 (0.61) -0.03 (-0.18–0.12)
Time between awakening and saliva sampling
�5 min 184 0.09 (0.22) -0.02 (-0.14–0.10)
6–10 min 94 -0.01 (0.96) -0.01 (-0.15–0.13)
Infant sex
Male 128 0.13 (0.15) 0.03 (-0.12–0.17)
Female 144 0.01 (0.91) -0.03 (-0.15–0.09)
a The TPDS was not included in PRIDE Study questionnaire Q2, but was completed on the day of saliva sampling by
women participating between December 2014 and May 2016.
b Low/moderate level of education includes no education, lower general secondary education, intermediate
vocational education, higher general secondary education, and pre-university education; High level of education
includes higher vocational education and university.
c BMI: Body Mass Index
https://doi.org/10.1371/journal.pone.0250459.t003
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rhythm of cortisol throughout the day. In a previous study we showed that a single awakening
salivary sample was reliable to identify pregnant women having elevated cortisol levels [11].
Timing of cortisol assessment is critical, however. Sequential collection in the morning pro-
vides information about the cortisol awakening response, whereas evening salivary cortisol
provides information on HPA activity. Although challenging regarding feasibility in large
study populations, sequential collection throughout the day provides information on the acro-
phase and amplitude of the circadian rhythm of cortisol. For feasibility reasons, we chose to
collect awakening cortisol levels, as salivary cortisol levels in samples collected immediately
after awakening have shown a higher day-to-day correlation compared to afternoon samples
[10]. Collecting only a single saliva sample in mid-pregnancy, we were not able to examine the
associations between psychological functioning and cortisol levels in early or late pregnancy
either. Since cortisol levels rise throughout the course of pregnancy [40], we may have missed
possible associations in early or late pregnancy. The salivary cortisol levels observed in our
study are substantially higher compared to levels in other studies, potentially due to differences
in study populations, analytical protocols, and sampling time. Salivary cortisol levels are
around twice as high in the morning compared to levels during the day and are two- to three-
fold higher in pregnant women compared to non-pregnant women. Averages above 3 ng/mL
have been seen in more studies in pregnant women, for example by Jones et al. [10] and Tsu-
bouchi et al. [41]. As we evaluated differences in salivary cortisol levels between groups of par-
ticipants within our study population, however, any deviations in cortisol levels from other
studies did not lead to bias in our results.
In conclusion, we cannot confirm that elevated cortisol levels in pregnant women are asso-
ciated with positive scores on self-completed questionnaires measuring pregnancy-related
anxiety, depressive symptoms, pregnancy distress, and maternal stress. The biological mecha-
nisms underlying the fluctuations in cortisol levels might be different than previously hypothe-
sized, resulting in self-completed questionnaires measuring other aspects. So the role of the
complex interplay of factors involved in the hyperactivity of the HPA axis including cortisol
remains unclear in depressed or stressed pregnant women. This might suggest that maternal
cortisol levels during pregnancy are mainly affected by biological and lifestyle factors, instead
of by psychological factors [42]. However, it does not suggest that elevated maternal cortisol
levels during pregnancy are harmless, as these have been associated with adverse pregnancy
outcomes, such as preterm birth and low birth weight, in previous studies [43, 44]. The etiol-
ogy and biological mechanisms underlying these associations are not fully explored yet, mak-
ing this an important topic for future research. Especially during the current COVID-19
pandemic, mental health is particularly relevant given visitation restrictions which complicate
participation of family members in the pregnancy trajectory and processes after birth of the
child. Longitudinal research is warranted to distinguish patterns of depressive symptoms and
stress disorders in pregnant women for targeted interventions.
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